Dcgi
-
{
- All
- News
- Videos
-
Sale Of False Version Of 2 Drugs To Be Monitored In India After WHO Alert
The Drugs Controller General of India has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified versions of two drugs.
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
Amazon, Flipkart, 20 Others Get Notice For Selling Drugs Without Licence
Amazon and Flipkart Health plus are among the 20 online sellers that have been issued show-cause notices by the Drugs Controller General of India (DCGI) over the online sale of drugs in violation of norms.
-
Rajeev Singh Raghuvanshi Appointed As Drugs Controller General Of India
The Union Public Service Commission (UPSC) has recommended the name of DrRajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).
-
WHO Drew Premature Link Between Gambia Child Deaths, Indian Cough Syrups: Drug Regulator
The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
Anti-Covid Pill Soon As Drug Regulator Approves Emergency Use
With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio
-
Drug Regulator Examining Zydus Cadila's Covid Vaccine For Children: Dr VK Paul
Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
-
Need Of 3rd Anti-Covid Dose Based More Upon Conjecture Than Data: Experts
More data is needed to establish if a third anti-COVID-19 booster dose will more effectively help in fighting the surge in infections in the country as currently its requirement has been based more upon conjecture, health experts said.
-
Covid Vaccine Must Have At Least 50% Efficacy For Wide Use: Drug Authority
The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
-
COVID-19 Kits Import Licence Of 3 Firms In India Cancelled After US Action
India's drug regulator has cancelled the rapid diagnostic kit import licenses of three firms and suspended that of 16 others saying the USFDA has removed the manufacturers from their list of coronavirus serology test kits with directions that they should not be distributed.
-
Sale Of False Version Of 2 Drugs To Be Monitored In India After WHO Alert
The Drugs Controller General of India has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified versions of two drugs.
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
Amazon, Flipkart, 20 Others Get Notice For Selling Drugs Without Licence
Amazon and Flipkart Health plus are among the 20 online sellers that have been issued show-cause notices by the Drugs Controller General of India (DCGI) over the online sale of drugs in violation of norms.
-
Rajeev Singh Raghuvanshi Appointed As Drugs Controller General Of India
The Union Public Service Commission (UPSC) has recommended the name of DrRajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).
-
WHO Drew Premature Link Between Gambia Child Deaths, Indian Cough Syrups: Drug Regulator
The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
Anti-Covid Pill Soon As Drug Regulator Approves Emergency Use
With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio
-
Drug Regulator Examining Zydus Cadila's Covid Vaccine For Children: Dr VK Paul
Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
-
Need Of 3rd Anti-Covid Dose Based More Upon Conjecture Than Data: Experts
More data is needed to establish if a third anti-COVID-19 booster dose will more effectively help in fighting the surge in infections in the country as currently its requirement has been based more upon conjecture, health experts said.
-
Covid Vaccine Must Have At Least 50% Efficacy For Wide Use: Drug Authority
The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
-
COVID-19 Kits Import Licence Of 3 Firms In India Cancelled After US Action
India's drug regulator has cancelled the rapid diagnostic kit import licenses of three firms and suspended that of 16 others saying the USFDA has removed the manufacturers from their list of coronavirus serology test kits with directions that they should not be distributed.
